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Abstract
In order to examine the descriptive validity of ICD-10
schizophrenia, 1,476 consecutively admitted in-patients
were included in the present study. ICD-10 schizophrenia
(n = 951) was compared with other non-affective psy-
chotic disorders [persistent delusional disorders (n = 51),
acute and transient psychotic disorders (n = 116) and
schizoaffective disorders (n = 354)] with respect to socio-
demographic, symptomatological and other clinical pa-
rameters. Analyses revealed that it is possible to distin-
guish schizophrenia from other non-affective psychotic
disorders according to ICD-10 criteria: schizophrenic pa-
tients were characterised by more pronounced negative
symptoms and a lower global functioning. They were
younger than patients with persistent delusional disor-
ders and schizoaffective disorders but older than pa-
tients with acute and transient psychotic disorders. The
results are in line with a high descriptive validity of ICD-
10 schizophrenia and highlight the importance of nega-
tive symptoms for this diagnosis.
Copyright © 2003 S. Karger AG, Basel
Introduction
More than 100 years ago, Kraepelin [1] divided func-
tional psychoses into ‘dementia praecox’, and ‘manic-
depressive insanity’. K. Schneider [2] reinforced this strict
dichotomous classification. His famous book Clinical
Psychopathology had a great influence on the psychiatric
classification. However, K. Schneider’s [2] dichotomous
classification was criticised for example by Strömgren [3]
because K. Schneider [2] did not mention the concept of
reactive psychoses, which was seen as an own entity sepa-
rated from schizophrenia. Strömgren [4] claimed that
these psychoses should be separated strictly from schizo-
phrenia because there are great differences between them,
not only with regard to the clinical picture but also prog-
nosis and required treatment. In contrast to schizophre-
nia, reactive psychoses are usually not associated with a
chronic course. Apart from the Scandinavian tradition of
reactive psychoses, other authors developed further diag-
nostic concepts, such as schizoaffective psychoses [5],
schizophreniform psychoses [6] and cycloid psychoses [7,
8]. In spite of several differences, these diverse labels all
denote psychotic disturbances with a brief duration and
remitting course, which are often associated with an acute
onset after psychosocial stressors [9].
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Neither the ICD-10 nor the DSM-IV follow K.
Schneider’s [2] dichotomous classification, but divide
functional, non-affective psychotic disorders into a vari-
ety of different subgroups. In ICD-10, these disorders are
classified in schizophrenia (F20), persistent delusional
disorders (F22), acute and transient psychotic disorders
(F23) and schizoaffective disorders (F25). This classifica-
tion has its roots in the historical concepts mentioned
above. Acute and transient psychotic disorders are in the
tradition of the concept of reactive psychoses, schizoaffec-
tive disorders are in the tradition of Kasanin’s [5] concept
and persistent delusional disorders have their origin in
Kraepelin’s [1] ‘paranoia’, a separate category for pure
delusional psychoses. In order to improve reliability and
validity, in ICD-10, diagnostic groups are operationalised
by descriptive criteria such as mode of onset, duration of
symptoms, prominence of affective symptoms, presence
of hallucinations and bizarre thinking or behaviour [10].
However, the principal question is whether or not
ICD-10 schizophrenia can be distinguished from the oth-
er non-affective psychotic disorders. In the present study,
descriptive validity will be investigated with regard to the
patients’ sociodemographic background, symptomatolog-
ical picture and other clinical parameters. A similar analy-
sis for DSM-III was published by Fabrega et al. [11]. The
present study focuses on a large and representative sample
of in-patients from a university hospital, thus allowing
determination of the sociodemographic and clinical simi-
larities and differences of ICD-10 schizophrenia and oth-
er non-affective psychotic disorders. The study tries to
answer the following three questions.
(1) Do patients with an ICD-10 diagnosis of schizo-
phrenia differ sociodemographically from patients with
other non-affective psychotic disorders?
(2) Do ICD-10 schizophrenic patients display a differ-
ent symptomatological picture than patients with other
non-affective psychotic disorders?
(3) Do ICD-10 schizophrenic patients differ from oth-
er non-affective psychotic patients with respect to other
clinical parameters?
Methods
The study was conducted in the Psychiatric Hospital of the Lud-
wig-Maximilians University, Munich, Germany. All consecutively
admitted in-patients of the years 1995–1999 with the diagnosis of
schizophrenia (F20), persistent delusional disorders (F22), acute and
transient psychotic disorders (F23), schizoaffective disorders (F25)
or other non-organic psychotic disorders/unspecified non-organic
psychoses (F28, F29) were included in the study. Therefore, the study
refers to a representative sample of in-patients admitted to a univer-
sity psychiatric department. Diagnoses were made by well-experi-
enced resident psychiatrists according to the clinical descriptions and
diagnostic guidelines for ICD-10 [12], and rater trainings were regu-
larly performed.
Psychopathological characteristics were prospectively assessed in
a standardised manner by using the AMDP system. The ratings were
performed on the day of admission and at discharge. Psychopatho-
logical rater trainings were regularly performed to establish a high
interrater reliability. The AMDP system was developed in Europe by
the Association for Methodology and Documentation in Psychiatry
in order to standardise the assessment of psychopathological symp-
toms, and is a comprehensive rating instrument that includes more
than 200 items. It is based on traditional descriptive psychopatholo-
gy and covers all psychopathological manifestations of functional
psychoses [13]. With the items ‘delusional perception’, ‘hearing of
voices’, ‘thought broadcasting’, ‘thought withdrawal’, ‘thought inser-
tion’ and ‘other experience of influence’, the AMDP system covers
important first-rank symptoms according to K. Schneider [2]. Each
item of the AMDP system can be graduated on a 4-point (0–3) scale.
Pietzcker et al. [14] extracted several psychopathological syndromes
by using the principal component analysis of the AMDP ratings. For
the purpose of the present study, the summary scores of the paranoid-
hallucinatory, manic and depressive syndromes [14] and the negative
syndrome [15] were calculated.
Psychosocial functioning was recorded by the Global Assessment
Scale (GAS) [16]. This is an internationally well-known single-
dimension rating scale for the evaluation of the overall functioning of
a subject on a continuum, from severe psychiatric illness (rated 0) to
health (rated 100). The GAS has 10 behavioural definitions, 1 for
each 10-point interval. It is not influenced by consideration of prog-
nosis, previous diagnosis, or the presumed nature of the underlying
disorder.
Information about sociodemographic parameters such as age,
marital status, social class (according to Hollingshead and Redlich)
and other clinical parameters such as duration of illness (time since
first occurrence of psychopathological symptoms) and presence of
psychosocial stressors prior to hospitalisation were derived from the
hospital’s computerised documentation system. The documentation
of these data is operationalised.
Differences between diagnostic groups for continuous variables
were evaluated using the t test. Group differences for all categorical
variables were evaluated using the ¯2 test. A p value of !0.05 (2-
tailed) was considered as statistically significant.
Results
Sample
Over the years 1995 to 1999, a total of 1,476 in-
patients [788 females (53.4%) and 688 males (46.6%)]
were included in the study. The mean age B SD of the
female patients was 41.7 B 13.6 years, and of the male
patients 34.6 B 11.9 years. Nine hundred and fifty-one
patients (64.4%) were diagnosed with schizophrenia
(F20), 51 (3.5%) with persistent delusional disorder
(F22), 116 (7.9%) with acute and transient psychotic dis-
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Table 1. Differences between ICD-10 schizophrenia and other psychotic disorders with respect to sociodemographic
parameters
Schizophrenia
(F20)
(n = 951)
Persistent delusional
disorders (F22)
(n = 51)
Acute and transient
psychotic disorders
(F23) (n = 116)
Schizoaffective
disorders (F25)
(n = 354)
Age1, years 37.1 (B13.3) 46.5 (B15.4) 34.4 (B10.8) 42.1 (B12.5)
t
Significance
–4.836
p ! 0.001
2.446
p = 0.016
–6.120
p ! 0.001
Gender (female), % 47.3 47.1 51.7 71.2
¯2
Significance
0.001
p = 0.971
0.804
p = 0.370
59.124
p ! 0.001
Marital status, %
Single 65.8 34.1 48.2 38.2
Married/stable partnership 20.3 43.9 37.5 44.2
Separated/divorced 11.2 17.1 14.3 12.7
Widowed 2.6 4.9 0 4.8
¯2
Significance
18.168
p ! 0.001
21.702
p ! 0.001
86.474
p ! 0.001
Social class, %
Higher (Hollingshead 1–3) 61.5 65.0 79.2 79.5
Medium (Hollingshead 4) 21.9 30.0 17.0 15.5
Lowest (Hollingshead 5) 16.5 5.0 3.8 5.0
¯2
Significance
4.364
p = 0.113
15.874
p ! 0.001
38.708
p ! 0.001
1 Figures in parentheses indicate mean B SD.
orders (F23), 354 (24.0%) with schizoaffective disorders
(F25) and 4 (0.3%) with other non-organic psychotic dis-
orders/unspecified non-organic psychoses (F28, F29). Be-
cause of its small size, the last group was not included in
the statistical evaluation.
Do Patients with an ICD-10 Diagnosis of
Schizophrenia Differ Sociodemographically from
Patients with Other Non-Affective Psychotic Disorders?
The comparison of demographical parameters re-
vealed the following results (table 1). Patients with ICD-
10 schizophrenia differed significantly from the other
three groups of non-affective psychotic disorders (persis-
tent delusional disorders, acute and transient psychotic
disorders and schizoaffective disorders) with respect to
age and marital status. Schizophrenic patients were more
often single than patients with other non-affective psy-
chotic disorders. They were younger than patients with
persistent delusional disorders and schizoaffective disor-
ders but older than patients with acute and transient psy-
chotic disorders.
Furthermore, the proportion of female patients in the
group of ICD-10 schizophrenia was lower than in the
group of patients with schizoaffective disorders. A smaller
percentage of the patients with ICD-10 schizophrenia
were in a higher social class than of those with acute and
transient psychotic disorders or schizoaffective disorders.
On the other hand, compared with the other three groups
of non-affective psychotic disorders, a higher percentage
of patients with ICD-10 schizophrenia were in the lowest
social class. However, the differences between patients
with ICD-10 schizophrenia and those with persistent
delusional disorders did not reach statistical significance.
Do ICD-10 Schizophrenic Patients Display a Different
Symptomatological Picture than Patients with Other
Non-Affective Psychotic Disorders?
The comparison of the mean values of the total scores
of the depressive, manic, paranoid-hallucinatory and neg-
ative syndromes (table 2) revealed the following results.
Patients with ICD-10 schizophrenia differed significantly
from patients with other non-affective psychotic disor-
Descriptive Validity of ICD-10
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Table 2. Differences between ICD-10 schizophrenia and other psychotic disorders with respect to the symptomato-
logical picture
Schizophrenia
(F20)
(n = 951)
Persistent delusional
disorders (F22)
(n = 51)
Acute and transient
psychotic disorders
(F23) (n = 116)
Schizoaffective
disorders (F25)
(n = 354)
Admission
First-rank symptoms, % 60.1 41.2 52.6 42.5
¯2 7.142 2.393 32.133
Significance p = 0.008 p = 0.122 p ! 0.001
Par.-hall. syndrome 7.9 (B6.7) 7.9 (B6.3) 7.5 (B6.0) 5.1 (B5.3)
t –0.107 0.441 7.828
Significance p = 0.915 p = 0.659 p ! 0.001
Negative syndrome 9.7 (B5.2) 4.6 (B3.9) 7.3 (B4.4) 7.8 (B5.7)
t 6.814 4.758 5.484
Significance p ! 0.001 p ! 0.001 p ! 0.001
Depressive syndrome 4.8 (B4.5) 5.4 (B5.2) 5.4 (B4.5) 8.3 (B6.6)
t –0.951 –1.328 –9.070
Significance p = 0.342 p = 0.185 p ! 0.001
Manic syndrome 2.0 (B2.9) 1.5 (B2.4) 2.5 (B3.0) 4.0 (B4.8)
t 1.116 –1.526 –7.005
Significance p = 0.244 p = 0.127 p ! 0.001
Discharge
First-rank symptoms, % 18.8 13.7 2.6 4.2
¯2 0.813 19.159 42.888
Significance p = 0.367 p ! 0.001 p ! 0.001
Par.-hall. syndrome 1.7 (B3.1) 2.6 (B3.5) 0.2 (B0.8) 0.3 (B1.1)
t –1.796 11.824 11.478
Significance p = 0.780 p ! 0.001 p ! 0.001
Negative syndrome 4.2 (B1.4) 1.4 (B2.0) 1.4 (B1.7) 1.7 (B2.4)
t 9.175 13.596 13.633
Significance p ! 0.001 p ! 0.001 p ! 0.001
Depressive syndrome 1.2 (B2.0) 0.9 (B1.5) 0.8 (B1.8) 1.1 (B2.0)
t 0.875 1.761 0.871
Significance p = 0.382 p = 0.780 p = 0.384
Manic syndrome 0.6 (B1.2) 0.3 (B0.8) 0.1 (B0.4) 0.8 (B1.8)
t 1.144 7.277 –2.159
Significance p = 0.360 p ! 0.001 p = 0.031
Figures in parentheses are mean B SD. Par.-hall. = Paranoid-hallucinatory.
ders with respect to the mean total score of the negative
syndrome both at time of admission and discharge. Mean
total scores of the negative syndrome were higher in
schizophrenic patients than in patients with other non-
affective psychotic disorders.
First-rank symptoms according to K. Schneider [2]
(‘delusional perception’, ‘hearing of voices’, ‘thought
broadcasting’, ‘thought withdrawal’, ‘thought insertion’ or
‘other experience of influence’) were common in all diag-
nostic groups. They did not allow differentiation between
ICD-10 schizophrenia and the other three groups of non-
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Table 3. Differences between ICD-10 schizophrenia and other psychotic disorders with respect to other clinical parameters
Schizophrenia
(F20)
(n = 951)
Persistent delusional
disorders (F22)
(n = 51)
Acute and transient
psychotic disorders
(F23) (n = 116)
Schizoaffective
disorders (F25)
(n = 354)
GAS at admission 37.4 (B14.1) 48.3 (B14.3) 40.8 (B17.7) 41.7 (B15.6)
t –5.339 –1.994 –4.531
Significance p ! 0.001 p = 0.048 p ! 0.001
GAS at discharge 58.3 (B15.1) 66.8 (B14.2) 70.9 (B13.9) 68.3 (B13.3)
t –3.982 –8.608 –11.688
Significance p ! 0.001 p ! 0.001 p ! 0.001
Psychosocial stressors prior to hospitalisation, % 16.4 24.4 34.8 25.7
¯2 1.792 22.368 13.750
Significance p = 0.181 p ! 0.001 p ! 0.001
Duration of illness, years 12.6 (B12.8) 12.3 (B17.6) 5.2 (B10.1) 13.3 (B13.1)
t 0.163 6.9 –0.789
Significance p = 0.871 p ! 0.001 p = 0.430
Figures in parentheses are mean B SD.
affective psychotic disorders. However, at the time of
admission, these symptoms were more frequent in schizo-
phrenic patients than in patients with persistent delusion-
al and schizoaffective disorders. At the time of discharge,
first-rank symptoms were more frequent in schizophrenic
patients than in patients with acute and transient psychot-
ic disorders and schizoaffective disorders.
Apart from the differences mentioned above, at the
time of admission, ICD-10 schizophrenia showed a high-
er mean total score for the paranoid-hallucinatory and a
lower mean total score for the depressive and manic syn-
dromes compared with schizoaffective disorders. A simi-
lar result was also found for the paranoid-hallucinatory
and the manic syndromes at discharge. Compared with
patients with acute and transient psychotic disorders,
schizophrenic patients showed higher mean total scores
for the paranoid-hallucinatory and manic syndromes at
discharge.
Do ICD-10 Schizophrenic Patients Differ from Other
Non-Affective Psychotic Patients with Respect to Other
Clinical Parameters?
The diagnostic groups were compared with respect to
global functioning at admission and discharge, measured
with GAS rating, presence of psychosocial stressors prior
to hospitalisation and duration of illness (time since first
occurrence of psychopathological symptoms; table 3).
In comparison with other non-affective psychotic dis-
orders, patients with ICD-10 schizophrenia showed a low-
er global functioning (mean value in GAS rating) both at
admission and discharge.
Psychosocial stressors prior to hospitalisation were less
frequent in patients with schizophrenia than in those with
acute and transient psychotic disorders and schizoaffec-
tive disorders. However, no significant differences were
found between schizophrenia and delusional disorders
with regard to psychosocial stressors prior to hospitalisa-
tion. Furthermore, patients with schizophrenia had a lon-
ger duration of illness than patients with acute and tran-
sient psychotic disorders. However, the duration of illness
in patients with delusional or schizoaffective disorders
was comparable with patients with schizophrenia.
Discussion
The aim of the present study was to investigate the
descriptive validity of ICD-10 schizophrenia. The crucial
question is whether it is possible to distinguish schizo-
phrenia from other non-affective psychotic disorders, as
suggested in ICD-10 and DSM-IV, or whether it is more
appropriate to follow K. Schneider’s [2] broad concept of
schizophrenia and talk about ‘schizophrenia spectrum
disorders’, like Angst and Scharfetter [17]. For this rea-
son, ICD-10 schizophrenia was compared with other non-
Descriptive Validity of ICD-10
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affective psychotic disorders of ICD-10 (persistent delu-
sional disorders, acute and transient psychotic disorders,
schizoaffective disorders) with regard to sociodemograph-
ic background, symptomatological picture and other clini-
cal parameters.
Differentiation between Schizophrenia and Other
Non-Affective Psychotic Disorders
In the study sample of 1,476 consecutively admitted
in-patients, 64.4% received a primary diagnosis of schizo-
phrenia, 3.5% of persistent delusional disorder, 7.9% of
acute and transient psychotic disorders, 24.0% of schi-
zoaffective disorders and 0.3% of other non-organic psy-
chotic disorders/unspecified non-organic psychoses.
These data reflect the frequency of ICD-10 diagnoses in
the clinical practice of a university psychiatric depart-
ment. Compared with other psychiatric hospitals in Ger-
many [18], a higher frequency of patients with schizoaf-
fective disorders and a lower one of patients with schizo-
phrenia was found. This difference may be due to the spe-
cial conditions of a university psychiatric department.
The major result of the present study was that it is pos-
sible to distinguish ICD-10 schizophrenia from other non-
affective psychotic disorders. Similar findings were re-
ported by Fabrega et al. [11] for DSM-III schizophrenia.
However, this statement is restricted by the fact that ICD-
10 field trials revealed a high interrater reliability for
schizophrenia, persistent delusional disorders and acute
and transient psychotic disorders, but only a moderate
one for schizoaffective disorders [19]. Schizophrenia is
the psychotic disorder that is characterised by more pro-
nounced negative symptoms and a lower global function-
ing in comparison with other psychotic disorders in ICD-
10. Schizophrenic patients were more often single persons
than those with other non-affective psychotic disorders.
They were younger than patients with persistent delusion-
al disorders and schizoaffective disorders, but older than
patients with acute and transient psychotic disorders.
However, the study design does not allow to give an
answer to the question discussed by Häfner et al. [20]
whether these parameters (age, marital status, negative
symptoms, global functioning) are independent from each
other or not.
Impact of Positive Symptoms
The results show that it is not possible to sufficiently
distinguish ICD-10 schizophrenia from the other non-
affective psychotic disorders by so-called ‘positive symp-
toms’ [21]. Similar findings were reported by Fabrega et
al. [11] for psychotic disorders in DSM-III. Neither the
paranoid-hallucinatory syndrome nor the first-rank
symptoms according to K. Schneider [2] allowed a differ-
entiation between ICD-10 schizophrenia and the other
groups of non-affective psychotic disorders. Although
first-rank symptoms were most common in ICD-10
schizophrenia, the differences were not statistically signif-
icant when ICD-10 schizophrenia was compared with
acute and transient psychotic disorders at admission and
persistent delusional disorders at discharge. However, the
definitions of first-rank symptoms in the AMDP are not
identical with K. Schneider’s [2] original phenomenologi-
cal descriptions and may invite to a superficial assessment
of false-positive symptoms [10]. The high frequency of
first-rank symptoms in persistent delusional disorders is
due to the symptom ‘delusional perception’. In contrast to
the ICD-10 diagnostic criteria for research [22], this
symptom is no explicit exclusion criterion for the diagno-
sis of a persistent delusional disorder in the clinical
descriptions and diagnostic guidelines of ICD-10 [12].
The results of the present study are in line with those
from Peralta and Cuesta [23], who examined 660 patients
with functional psychoses according to DSM-III-R crite-
ria and found that first-rank symptoms do not have any
diagnostic significance for schizophrenia relative to other
psychotic disorders like schizophreniform disorders, schi-
zoaffective disorders or brief reactive psychoses. These
findings are not surprising because K. Schneider [2] never
intended that his first-rank symptoms should distinguish
between schizophrenia and other non-affective psychotic
disorders, but only between ‘schizophrenia’ and ‘cyclothy-
mia’ (affective disorders). He claimed that one ‘has to
speak about schizophrenia’, if one can find any first-rank
symptom in the absence of an organic brain disease.
Impact of Negative Symptoms
However, the results of the present study highlight the
importance of negative symptoms for the diagnosis of
ICD-10 schizophrenia. With respect to the clinical pic-
ture, only the negative syndrome allows one to distinguish
between ICD-10 schizophrenia and other non-affective
psychotic disorders. The results are in line with those
from other studies, which have shown that with regard to
negative symptoms, there are significant differences be-
tween schizophrenia and schizoaffective disorders (ICD-
10) [24] as well as between schizophrenia and schizophre-
niform disorders (DSM-III) [25]. Although these symp-
toms have already been described by Kraepelin [1] and
Bleuler [26], the concept of negative symptoms became
more popular after 1980 [21, 27]. Several studies have
shown that pronounced negative symptoms are associated
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with an unfavourable course and worse social functioning
in schizophrenic patients [28–30]. The results of the
present study are in line with these findings because, in
addition to pronounced negative symptoms, the group of
schizophrenic patients was characterised by lower global
functioning and a higher frequency of single persons than
the groups of other non-affective psychotic disorders.
This is also compatible with the Scandinavian tradition.
In contrast to K. Schneider [2], the Scandinavian concept
of schizophrenia, often referred to as ‘nuclear schizophre-
nia’ or ‘process schizophrenia’ [31], is narrower because it
usually considers schizophrenia as a chronic disorder,
separate from reactive psychoses [4, 32].
Limitations and Conclusions
The results of the present study provide some evidence
for a high descriptive validity of ICD-10 schizophrenia.
According to Feinstein [33], diagnostic systems should be
investigated not only with respect to descriptive or inter-
nal validity but also to external validity. Validation is
internal if one uses parameters that are part of the diag-
nostic judgement, such as the psychopathological picture
or previous course of illness. For an external validation, it
is necessary to test diagnostic groups with respect to
parameters that are not available at the time of diagnostic
judgement. The most common form of external valida-
tion is the investigation of future course and outcome
(predictive validity). The present study is limited by its
cross-sectional design. Until now, only a few studies have
analysed the predictive validity of schizophrenia in com-
parison with other non-affective psychotic disorders ac-
cording to ICD-10 criteria in a longitudinal design [34–
38]. These investigations provide some evidence that
ICD-10 schizophrenia is associated with a more chronic
course and unfavourable outcome than other non-affec-
tive psychotic disorders. The division of psychotic disor-
ders into different diagnostic subgroups, as suggested in
ICD-10, seems to have a prognostic impact. However, it is
necessary to perform further studies to expand the empiri-
cal data base in this field of psychiatric research.
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